固肠止泻丸联合思密达治疗腹泻型肠易激综合征疗效观察  被引量:4

固肠止泻丸联合思密达治疗腹泻型肠易激综合征疗效观察

在线阅读下载全文

作  者:黄惠风[1] 季顺祥[1] 

机构地区:[1]江苏省姜堰市中医院,姜堰225500

出  处:《实用中西医结合临床》2006年第6期11-12,共2页Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine

摘  要:目的:探讨固肠止泻丸联合思密达对腹泻型肠易激综合征(IBS)的治疗价值。方法:将68例腹泻型IBS患者随机分为3组:A组25例,为固肠止泻丸联合思密达治疗组;B组22例,为固肠止泻丸治疗组;C组21例,为思密达治疗组。观察患者治疗前后症状好转情况。结果:A组总有效率为84%,较B、C2组差异有统计学意义(P<0.05)。结论:固肠止泻丸和思密达联合治疗腹泻型IBS优于固肠止泻丸及思密达单一用药。Objective:To study the therapeutic effect of combining Guchangzhixie Wan with Smecta in treating irritable bowel syndrome (IBS) of diarrheal type.Methods:68 patients were randomly divided into three groups: group A,treated with Guchangzhixie Wan and Smecta,n=25; group B,treated with Guchangzhixie Wan,n=22;group C,treated with Smecta,n=21 .After two months,the general status were observed and recorded. Results:The general effective rate of group A was 84%.It was significantly better than that in group B and group C (P 〈0.05). Conclusion:The therapeutic effect of combining Guchangzhixie Wan with Smecta in treatment of IBS of diarrheal type is superior to Guchangzhixie Wan and Smecta alone.

关 键 词:肠易激综合征 固肠止泻丸 思密达 中西医结合疗法 疗效观察 

分 类 号:R574.4[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象